What physicians and health organizations should know about mandated imaging appropriate use criteria

Keith D. Hentel, Andrew Menard, John Mongan, Jeremy C. Durack, Pamela Johnson, Ali S. Raja, Ramin Khorasani

Research output: Contribution to journalArticle

Abstract

The Appropriate Use Criteria Program, enacted by the Centers for Medicare & Medicaid Services in response to the Protecting Access to Medicare Act of 2014 (PAMA), aims to reduce inappropriate and unnecessary imaging by mandating use of clinical decision support (CDS) by all providers who order advanced imaging examinations (magnetic resonance imaging; computed tomography; and nuclear medicine studies, including positron emission tomography). Beginning 1 January 2020, documentation of an interaction with a certified CDS system using approved appropriate use criteria will be required on all Medicare claims for advanced imaging in all emergency department patients and outpatients as a prerequisite for payment. The Appropriate Use Criteria Program will initially cover 8 priority clinical areas, including several (such as headache and low back pain) commonly encountered by internal medicine providers. All providers and organizations that order and provide advanced imaging must understand program requirements and their options for compliance strategies. Substantial resources and planning will be needed to comply with PAMA regulations and avoid unintended negative consequences on workflow and payments. However, robust evidence supporting the desired outcome of reducing inappropriate use of advanced imaging is lacking.

Original languageEnglish (US)
Pages (from-to)880-885
Number of pages6
JournalAnnals of internal medicine
Volume170
Issue number12
DOIs
StatePublished - Jun 18 2019

    Fingerprint

ASJC Scopus subject areas

  • Internal Medicine

Cite this